| Prev Close: | 66.16 |
|---|---|
| Open: | 65.75 |
| Bid: | 65.64 x 200 |
| Ask: | 65.69 x 1000 |
| NAV¹: | 34.88 |
| Net Assets²: | 721.03M |
| YTD Return (Mkt)²: | 32.99% |
| Day's Range: | 65.54 - 66.05 |
|---|---|
| 52wk Range: | 41.44 - 67.20 |
| Volume: | 28,558 |
| Avg Vol (3m): | 140,083 |
| P/E (ttm)²: | 30 |
| Yield (ttm)²: |
¹As of Nov 29, 2012
²As of Aug 30, 2013
Headlines
- Biotech ETFs: Outstanding Risk-Adjusted Portfoliosat Seeking Alpha(Sun, Sep 22)
- 3 Lower-Risk Ways to Invest in Health Careat Motley Fool(Fri, Sep 6)
- How To Avoid The Worst Sector ETFsat Seeking Alpha(Wed, Aug 21)
- How To Find The Best Sector ETFsat Seeking Alpha(Tue, Aug 20)
- First Trust NYSE Arca Biotechnology Index Fund Experiences Big Inflowat Forbes(Fri, Jul 19)
- Notable ETF Inflow Detected - FBTat Forbes(Tue, Jul 9)
- FBT, C: ETF Inflow Alertat Forbes(Thu, Jun 27)
- Genome Research Benefits Growing, Getting Cheaperat CNBC(Sun, Jun 16)
- Zacks Investment Ideas feature highlights: Market Vectors Biotech ETF, iShares Nasdaq Biotechnology ETF, Regeneron, Celgene and First Trust Amex Biotechnology Index FundZacks(Wed, Jun 12)
- 3 Impressive Biotech ETFs Crushing the MarketZacks(Tue, Jun 11)
- FIRST TRUST EXCHANGE-TRADED FUND FinancialsEDGAR Online Financials(Thu, Jun 6)
- Healthcare ETFs Will Perk Up Your Portfolioat Seeking Alpha(Mon, Jun 3)
- Biotech ETF Rallies Over 30% as Cash Tumbles InETF Trends(Wed, May 22)
- Biotechnology ETF Investing 101Zacks(Mon, May 20)
- A Journey To Add Biotech To The Portfolioat Seeking Alpha(Sat, May 18)
Reports
- FBT: Fundamental Valuation and Predictive Rating ReportNew Constructs, LLC(Oct 2)
- ValuEngine Industry Report for Finance-public TD INV FDValuEngine, Inc.(Oct 2)
- FIRST TRUST AMEX BIOTECHNOLOGY (FBT) - REPORT FOR ACTIVE TRADERSPechala's Reports(Sep 30)
